Scott Platshon joined EcoR1 Capital as a Principal in 2015. EcoR1 Capital is a fundamental biotechnology-focused investment firm in San Francisco. He serves as a board observer for Kumquat Biosciences, Ashvattha Therapeutics and Orpheris Inc. Prior to EcoR1 Capital, he was an analyst for Aquilo Partners, a boutique life-science investment bank. Scott holds a Bachelor of Science in Bioengineering from Stanford University.